KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Net Margin (2016 - 2025)

Historic Net Margin for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to 39.28%.

  • Gilead Sciences' Net Margin rose 226800.0% to 39.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 27.88%, marking a year-over-year increase of 274800.0%. This contributed to the annual value of 1.67% for FY2024, which is 190300.0% down from last year.
  • As of Q3 2025, Gilead Sciences' Net Margin stood at 39.28%, which was up 226800.0% from 27.69% recorded in Q2 2025.
  • Gilead Sciences' Net Margin's 5-year high stood at 39.28% during Q3 2025, with a 5-year trough of 62.38% in Q1 2024.
  • Moreover, its 5-year median value for Net Margin was 22.1% (2022), whereas its average is 17.18%.
  • As far as peak fluctuations go, Gilead Sciences' Net Margin surged by 915800bps in 2021, and later crashed by -778800bps in 2024.
  • Over the past 5 years, Gilead Sciences' Net Margin (Quarter) stood at 5.19% in 2021, then surged by 326bps to 22.1% in 2022, then fell by -10bps to 19.9% in 2023, then rose by 18bps to 23.54% in 2024, then soared by 67bps to 39.28% in 2025.
  • Its last three reported values are 39.28% in Q3 2025, 27.69% for Q2 2025, and 19.72% during Q1 2025.